Silexion Therapeutics Corp has split its stock 4 times since its initial public offering (IPO). The first stock split occurred on November 29, 2024 with the ratio of 1-for-9, meaning that for 9 shares of SLXN owned pre-split, shareholders then owned 1 share. 3 more splits have been implemented since then. The most recent stock split took place on May 29, 2026 on a 1-for-10 basis.
These splits have increased SLXN stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Silexion Therapeutics Corp's total market capitalization.
For more detailed information of Silexion Therapeutics Corp's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Silexion Therapeutics Corp has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when SLXN stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Silexion Therapeutics Corp's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
